Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury

Experimental Neurology

Volumn 231, Issue 1, 2011, Pages 135-146

  Labombarda, Florencia ^a,b   González, Susana ^a,b   Lima, Analia ^b   Roig, Paulina ^b   Guennoun, Rachida ^c   Schumacher, Michael ^c   De Nicola, Alejandro F ^a,b  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Universite Paris Sud   (France)

Author keywords

Astrogliosis; Microgliosis; Neuroprotection; Oligodendrocytes; Progesterone; Spinal cord injury

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROGESTERONE; PROTEIN S100B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL COUNT; CELL DENSITY; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLIA CELL; GLIOSIS; MACROPHAGE; MALE; MICROGLIA; MICROGLIOSIS; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; SPINAL CORD INJURY; TREATMENT DURATION;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; MALE; MICROGLIA; MYELITIS; OLIGODENDROGLIA; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; STEM CELLS;

EID: 79961021467     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.06.001     Document Type: Article

References (88)

1. Alonso G. NG2 proteoglycan-expressing cells of the adult rat brain: possible involvement in the formation of glial scar astrocytes following stab wound. Glia 2005, 49:318-338.
2. Arevalo M.A., Santos-Galindo M., Bellini M.J., Azcoitia I., Garcia-Segura L.M. Actions of estrogens on glial cells: implications for neuroprotection. Biochim. Biophys. Acta 2009, 1800:1106-1112.
3. Arnold S., de Araujo G.W., Beyer C. Gender-specific regulation of mitochondrial fusion and fission gene transcription and viability of cortical astrocytes by steroid hormones. J. Mol. Endocrinol. 2008, 41:289-300.
4. Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L.M., Melcangi R.C. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 2003, 24:853-860.
5. Barker J.M., Galea L.A. Repeated estradiol administration alters different aspects of neurogenesis and cell death in the hippocampus of female but not male rats. Neuroscience 2008, 152:888-902.
6. Batchelor P.E., Tan S., Wills T.E., Porritt M.J., Howells D.W. Comparison of inflammation in the brain and spinal cord following mechanical injury. J. Neurotrauma 2008, 25:1217-1225.
7. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001, 81:871-927.
8. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin. Proc. 2005, 80:1326-1338.
9. Bezzi P., Volterra A. A neuron-glia signalling network in the active brain. Curr. Opin. Neurobiol. 2001, 11:387-394.
10. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
11. Brambilla R., Persaud T., Hu X., Karmally S., Shestopalov V.I., Dvoriantchikova G., Ivanov D., Nathanson L., Barnum S.R., Bethea J.R. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 2009, 182:2628-2640.
12. Brozzi F., Arcuri C., Giambanco I., Donato R. S100B protein regulates astrocyte shape and migration via Interaction with Src kinase: implications for astrocyte development, activation and tumor growth. J. Biol. Chem. 2009, 284:8797-8811.
13. Buffo A., Rite I., Tripathi P., Lepier A., Colak D., Horn A.P., Mori T., Gotz M. Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3581-3586.
14. Ciriza I., Azcoitia I., Garcia-Segura L.M. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 2004, 16:58-63.
15. Coughlan T., Gibson C., Murphy S. Modulatory effects of progesterone on inducible nitric oxide synthase expression in vivo and in vitro. J. Neurochem. 2005, 93:932-942.
16. Crossin K.L., Tai M.H., Krushel L.A., Mauro V.P., Edelman G.M. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2687-2692.
17. Cutler S.M., Cekic M., Miller D.M., Wali B., VanLandingham J.W., Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 2007, 24:1475-1486.
18. De Nicola A.F., Gonzalez S.L., Labombarda F., Gonzalez Deniselle M.C., Garay L., Guennoun R., Schumacher M. Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination. J. Mol. Neurosci. 2006, 28:3-15.
19. De Nicola A.F., Labombarda F., Gonzalez Deniselle M.C., Gonzalez S.L., Garay L., Meyer M., Gargiulo G., Guennoun R., Schumacher M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol. 2009, 30:173-187.
20. Djebaili M., Lerner-Natoli M., Montpied P., Baille V., Bockaert J., Rondouin G. Molecular events involved in neuronal death induced in the mouse hippocampus by in-vivo injection of kainic acid. Brain Res. Mol. Brain Res. 2001, 93:190-198.
21. Djebaili M., Guo Q., Pettus E.H., Hoffman S.W., Stein D.G. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 2005, 22:106-118.
22. Drew P.D., Chavis J.A. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 2000, 111:77-785.
23. Gago N., Akwa Y., Sananes N., Guennoun R., Baulieu E.E., El-Etr M., Schumacher M. Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism. Glia 2001, 36:295-308.
24. Gago N., El-Etr M., Sananes N., Cadepond F., Samuel D., Avellana-Adalid V., Baron-Van Evercooren A., Schumacher M. 3alpha,5alpha-tetrahydroprogesterone (allopregnanolone) and gamma-aminobutyric acid: autocrine/paracrine interactions in the control of neonatal PSA-NCAM+ progenitor proliferation. J. Neurosci. Res. 2004, 78:770-783.
25. Garay L., Gonzalez Deniselle M.C., Lima A., Roig P., De Nicola A.F. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 2007, 107:228-237.
26. Garay L., Gonzalez Deniselle M.C., Gierman L., Meyer M., Lima A., Roig P., De Nicola A.F. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008, 15:76-83.
27. Garcia-Estrada J., Luquin S., Fernandez A.M., Garcia-Segura L.M. Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci. 1999, 17:145-151.
28. Garcia-Segura L.M., Melcangi R.C. Steroids and glial cell function. Glia 2006, 54:485-498.
29. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., Baulieu E.E., Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 2003, 86:848-859.
30. Ghoumari A.M., Baulieu E.E., Schumacher M. Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 2005, 135:47-58.
31. Ghoumari A.M., Piochon C., Tomkiewicz C., Eychenne B., Levenes C., Dusart I., Schumacher M., Baulieu E.E. Neuroprotective effect of mifepristone involves neuron depolarization. FASEB J. 2006, 20:1377-1386.
32. Gonzalez Deniselle M.C., Garay L., Gonzalez S., Saravia F., Labombarda F., Guennoun R., Schumacher M., De Nicola A.F. Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons. Exp. Neurol. 2007, 203:406-414.
33. Gonzalez S.L., Labombarda F., Gonzalez Deniselle M.C., Guennoun R., Schumacher M., De Nicola A.F. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 2004, 125:605-614.
34. Gonzalez S.L., Lopez-Costa J.J., Labombarda F., Gonzalez Deniselle M.C., Guennoun R., Schumacher M., De Nicola A.F. Progesterone effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (MAP2) in rats with acute spinal cord injury. Cell. Mol. Neurobiol. 2009, 29:27-39.
35. Grossman S.D., Rosenberg L.J., Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 2001, 168:273-282.
36. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
37. Hausmann O.N. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003, 41:369-378.
38. Horky L.L., Galimi F., Gage F.H., Horner P.J. Fate of endogenous stem/progenitor cells following spinal cord injury. J. Comp. Neurol. 2006, 498:525-538.
39. Hu R., Zhou J., Luo C., Lin J., Wang X., Li X., Bian X., Li Y., Wan Q., Yu Y. Glial scar and neuroregeneration: histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury. J. Neurosurg. Spine 2010, 13:169-180.
40. Ibanez C., Shields S.A., El-Etr M., Baulieu E.E., Schumacher M., Franklin R.J. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 2004, 30:80-89.
41. Jung-Testas I., Schumacher M., Robel P., Baulieu E.E. Demonstration of progesterone receptors in rat Schwann cells. J. Steroid Biochem. Mol. Biol. 1996, 58:77-82.
42. Kipp M., Karakaya S., Johann S., Kampmann E., Mey J., Beyer C. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes. J. Neuroendocrinol. 2007, 19:819-822.
43. Koenig H.L., Schumacher M., Ferzaz B., Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 1995, 268:1500-1503.
44. Labombarda F., Gonzalez S., Roig P., Lima A., Guennoun R., Schumacher M., De Nicola A.F. Modulation of NADPH-diaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured rat spinal cord. J. Steroid Biochem. Mol. Biol. 2000, 73:159-169.
45. Labombarda F., Guennoun R., Gonzalez S., Roig P., Lima A., Schumacher M., De Nicola A.F. Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord. Neurosci. Lett. 2000, 288:29-32.
46. Labombarda F., Gonzalez S.L., Gonzalez D.M., Guennoun R., Schumacher M., De Nicola A.F. Cellular basis for progesterone neuroprotection in the injured spinal cord. J. Neurotrauma 2002, 19:343-355.
47. Labombarda F., Gonzalez S., Gonzalez Deniselle M.C., Garay L., Guennoun R., Schumacher M., De Nicola A.F. Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord. J. Neurotrauma 2006, 23:181-192.
48. Labombarda F., Pianos A., Liere P., Eychenne B., Gonzalez S., Cambourg A., De Nicola A.F., Schumacher M., Guennoun R. Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology 2006, 147:1847-1859.
49. Labombarda F., Gonzalez S.L., Lima A., Roig P., Guennoun R., Schumacher M., De Nicola A.F. Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 2009, 5:884-897.
50. Labombarda F., Gonzalez Deniselle M.C., De Nicola A.F., Gonzalez S.L. Progesterone and the spinal cord: good friends in bad times. Neuroimmunomodulation 2010, 17:146-149.
51. Labombarda F., Meffre D., Delespierre B., Krivokapic-Blondiaux S., Chastre A., Thomas P., Pang Y., Lydon J.P., Gonzalez S.L., De Nicola A.F. Membrane progesterone receptors localization in the mouse spinal cord. Neuroscience 2010, 166:94-106.
52. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007, 144:1293-1304.
53. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 2001, 24:39-47.
54. Ling E.A., Kaur L.C., Yick T.Y., Wong W.C. Immunocytochemical localization of CR3 complement receptors with OX-42 in amoeboid microglia in postnatal rats. Anat. Embryol. (Berl) 1990, 182:481-486.
55. Lorenz L., Dang J., Misiak M., Tameh Abolfazl A., Beyer C., Kipp M. Combined 17beta-oestradiol and progesterone treatment prevents neuronal cell injury in cortical but not midbrain neurones or neuroblastoma cells. J. Neuroendocrinol. 2009, 21:841-849.
56. McDonald J.W., Belegu V. Demyelination and remyelination after spinal cord injury. J. Neurotrauma 2006, 23:345-359.
57. McTigue D.M., Wei P., Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 2001, 21:3392-33400.
58. Melcangi R.C., Magnaghi V., Cavarretta I., Riva M.A., Piva F., Martini L. Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging. Exp. Gerontol. 1998, 33:827-836.
59. Meyer M., Gonzalez Deniselle M.C., Garay L.I., Monachelli G.G., Lima A., Roig P., Guennoun R., Schumacher M., De Nicola A.F. Stage dependent effects of progesterone on motoneurons and glial cells of Wobbler mouse spinal cord degeneration. Cell. Mol. Neurobiol. 2010, 30:123-135.
60. Mitterling K.L., Spencer J.L., Dziedzic N., Shenoy S., McCarthy K., Waters E.M., McEwen B.S., Milner T.A. Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampus. J. Comp. Neurol. 2010, 518:2729-2743.
61. Morin-Richaud C., Feldblum S., Privat A. Astrocytes and oligodendrocytes reactions after a total section of the rat spinal cord. Brain Res. 1998, 783:85-101.
62. Muller E., Kerschbaum H.H. Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuroendocrinol. Lett. 2006, 27:675-678.
63. Norenberg M.D. Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 1994, 53:213-220.
64. Ogata T., Nakamura .Y., Tsuji K., Shibata T., Kataoka K. Steroid hormones protect spinal cord neurons from glutamate toxicity. Neuroscience 1993, 55:445-449.
65. Pettus E.H., Wright D.W., Stein D.G., Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005, 1049:112-119.
66. Rabchevsky A.G., Sullivan P.G., Scheff S.W. Temporal-spatial dynamics in oligodendrocyte and glial progenitor cell numbers throughout ventrolateral white matter following contusion spinal cord injury. Glia 2007, 55:831-843.
67. Revsin Y., Saravia F., Roig P., Lima A., de Kloet E.R., Homo-Delarche F., De Nicola A.F. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res. 2005, 1038:22-31.
68. Robertson C.L., Puskar A., Hoffman G.E., Murphy A.Z., Saraswati M., Fiskum G. Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp. Neurol. 2006, 197:235-243.
69. Roglio I., Giatti S., Pesaresi M., Bianchi R., Cavaletti G., Lauria G., Garcia-Segura L.M., Melcangi R.C. Neuroactive steroids and peripheral neuropathy. Brain Res. Rev. 2008, 57:460-469.
70. Rosenberg L.J., Zai L.J., Wrathall J.R. Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. Glia 2005, 49:107-120.
71. Siegenthaler M.M., Tu M.K., Keirstead H.S. The extent of myelin pathology differs following contusion and transection spinal cord injury. J. Neurotrauma 2007, 24:1631-1646.
72. Sierra A., Gottfried-Blackmore A., Milner T.A., McEwen B.S., Bulloch K. Steroid hormone receptor expression and function in microglia. Glia 2008, 56:659-674.
73. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
74. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci. 2001, 24:386-391.
75. Stein D.G. The case for progesterone. Ann. N. Y. Acad. Sci. 2005, 1052:152-169.
76. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 2008, 57:386-397.
77. Stein D.G., Wright D.W. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin. Investig. Drugs 2010, 19:847-857.
78. Suyama K., Watanabe M., Sakai D., Osada T., Imai M., Mochida J. Nkx2.2 expression in differentiation of oligodendrocyte precursor cells and inhibitory factors for differentiation of oligodendrocytes after traumatic spinal cord injury. J. Neurotrauma 2007, 24:1013-1025.
79. Totoiu M., Keirstead H. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 2005, 486:373-383.
80. Trivedi A., Olivas A.D., Noble-Haeusslein L.J. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin. Neurosci. Res. 2006, 6:283-292.
81. Wang D.D., Bordey A. The astrocyte odyssey. Prog. Neurobiol. 2008, 86:342-367.
82. Waters E.M., Torres-Reveron A., McEwen B.S., Milner T.A. Ultrastructural localization of extranuclear progestin receptors in the rat hippocampal formation. J. Comp. Neurol. 2008, 51:34-46.
83. Watson C., Paxinos G., Kayalioglu G. The Spinal Cord 2009, Academic Press, New York.
84. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402.
85. Wu J., Yoo S., Wilcock D., Lytle J.M., Leung P.Y., Colton C.A., Wrathall J.R. Action of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia 2010, 58:410-422.
86. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care 2008, 12:R61.
87. Zai, L.J., Wrathall, J.R., 2005. Cell proliferation and replacement following contusive spinal cord injury. Glia 50, 247-257.
88. Zai L.J., Yoo S., Wrathall J.R. Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res. 2005, 1052:147-155.